We describe our initial experience with integrated whole-body Fluor-18-Fluordesoxyglucose-PET/MR imaging in children in a retrospective study of all 18F-FDG-PET/MR at our institution. 51 studies were carried out in 41 children (34 girls, 17 boys) with a mean age of 10.16 years (10 months-24 years). Primary diagnosis included rhabdomyosarcoma (n=18) and Osteosarcoma (n=5). The majority of studies (n=29, 57.9%) were performed for treatment response/restaging. All studies were diagnostic (technical success rate 100%). The mean effective dose was 5.25 mSv (2.1-11.5 mSv). Mean total imaging time was 80 minutes (42-138 minutes). Thirty-eight (74.5%) cases had an average of 2.2 additional MR sequences. 18F-FDG PET/MR is technically feasible for the evaluation of oncologic processes in children at a fraction of the radiation dose.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords